We're exiting our remaining stake in an industrial stock spin-off gone wrong

Jim Cramer's Charitable Trust is exiting its remaining 110-share Honeywell Technologies position at about $209 per share, realizing an approximately 3% loss and replenishing cash. The article says 2027 EPS consensus of $9.81 may be too high: applying management's stated 15% growth expectation to the high end of 2026 guidance, $8.35 per share, implies about $9.60 for 2027. Honeywell shares rose about 1% Wednesday after announcing an AI platform developed with Nvidia and Dell, but the Trust cited estimate risk and potential economic weakness from rising rates in its decision to sell.

Analysis

The key issue is not the exit by a small, public-facing portfolio, but the potential gap between management’s 2027 growth framing and the earnings base implied by current estimates. Using the article’s assumptions, the implied 2027 EPS is below consensus; if investors begin anchoring to the lower figure, estimate revisions—not the launch of an AI platform—are the more consequential near-term driver for HON’s multiple.

The AI announcement may help Honeywell defend customer relationships, but it does not establish material incremental revenue, pricing power, or adoption. In the near term, NVDA and Dell are better viewed as technology enablers than meaningful beneficiaries of this specific deployment absent scale or commercial terms. A second-order risk for industrial automation vendors is that customers may expect software-led efficiency gains to lower operating costs, increasing pressure to demonstrate measurable returns and renewals.

Over 1–3 months, watch HON guidance and sell-side 2027 revisions alongside rates and industrial demand. Over 6–18 months, standalone execution and the ability to convert digital-twin deployments into recurring, monetizable software matter more than launch announcements. The bearish thesis is falsified if HON delivers growth consistent with its stated 2027 ambition and consensus estimates stabilize or rise. Conversely, downward revisions without a demand shock would indicate the estimate reset is company-specific. The public sale itself is a weak signal; it should not be treated as evidence of broad institutional positioning.

Key Decisions for Investors

• Do not trade the small portfolio exit as a standalone catalyst. Maintain a cautious/underweight stance on HON rather than chase the post-announcement rebound.
• Treat a short HON position as conditional, not immediate: consider it only if upcoming guidance or analyst revisions confirm 2027 EPS is moving below the current consensus trajectory. Reassess if estimates stabilize or management provides credible evidence of delivery.
• Track HON’s next earnings update for the specific falsifiers: 2026 EPS guidance, confirmation or revision of the 2027 growth outlook, and evidence that AI deployments translate into paid adoption or recurring revenue.
• Do not infer a material earnings catalyst for NVDA or Dell from this collaboration alone; revisit only if the companies disclose deployment scale, commercial economics, or meaningful contribution to guidance.